Target intelligence / Profile preview

Nestin (NES) (NES)

Target
NES
Molecular classification
Intermediate filament, Cytoskeletal protein, Marker protein
01

Overview

Nestin is a type VI intermediate filament protein that serves as a hallmark of neural progenitor cells and is significantly upregulated in glioblastoma multiforme (GBM) (Dahlstrand et al., 1992; PMID: 15150103). The glioma-associated nestin promoter / transcriptional state refers to the specific regulatory environment in which the Nestin gene is active, characterizing a population of glioma stem cells (GSCs) that drive tumor growth and recurrence (Neftel et al., 2019; PMID: 31327413). This transcriptional state is a focal point for therapeutic development, particularly in gene therapy, where the Nestin promoter is used to drive the selective expression of oncolytic viruses or cytotoxic genes within tumor cells (Kambara et al., 2005; PMID: 15611137). For example, the oncolytic virus rQNestin34.5 utilizes the Nestin promoter to ensure viral replication is restricted to Nestin-expressing glioma cells, thereby minimizing damage to healthy brain tissue (Ishiwata et al., 2011; PMID: 21415461). Consequently, while Nestin itself is a structural protein, its promoter and the associated transcriptional state represent a critical molecular switch for precision oncology in high-grade gliomas.

Other names
NESIntermediate filament protein nestinType VI intermediate filamentNestin promoter
02

Mechanism of action

Promoter-driven selective expression of therapeutic genes or oncolytic viral replication within Nestin-positive glioma cells.

03

Biological functions

Cell proliferationCytoskeleton organizationNeural stem cell maintenanceCell migration
04

Disease associations

CancerGlioblastomaGlioma
05

Safety considerations

Off-target effects on endogenous neural stem cells in the subventricular zoneBlood-brain barrier delivery challengesPotential for viral-induced neuroinflammation
06

Interacting drugs

rQNestin34.5

1 more in the full profile.

07

Biomarkers

Nestin protein expression (IHC)Nestin mRNA levelsNestin-positive glioma stem cell count

Beyond the preview

Go deeper on Nestin (NES) (NES).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nestin (NES) (NES).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call